Medidex is not a provider of medical services and all information is provided for the convenience of the user. No medical decisions should be made based on the information provided on this website without first consulting a licensed healthcare provider.This website is intended for persons 18 years or older. No person under 18 should consult this website without the permission of a parent or guardian.
Epinastine Hydrochloride
×
Overview
What is Epinastine Hydrochloride?
Epinastine HCl Ophthalmic Solution 0.05%
Epinastine HCl is represented by the following structural formula:
CHNHCl Mol. Wt. 285.78
What does Epinastine Hydrochloride look like?
What are the available doses of Epinastine Hydrochloride?
What should I talk to my health care provider before I take Epinastine Hydrochloride?
How should I use Epinastine Hydrochloride?
Epinastine HCl Ophthalmic Solution 0.05%
The recommended dosage is one drop in each eye twice a day.
Treatment should be continued throughout the period of exposure (i.e., until the pollen season is over or until exposure to the offending allergen is terminated), even when symptoms are absent.
What interacts with Epinastine Hydrochloride?
Sorry No Records found
What are the warnings of Epinastine Hydrochloride?
Sorry No Records found
What are the precautions of Epinastine Hydrochloride?
Sorry No Records found
What are the side effects of Epinastine Hydrochloride?
Sorry No records found
What should I look out for while using Epinastine Hydrochloride?
None
Potential for
Sulfamethoxazole and Trimethoprim
to Affect Other Drugs
via
What might happen if I take too much Epinastine Hydrochloride?
Sorry No Records found
How should I store and handle Epinastine Hydrochloride?
Product: 50090-1635NDC: 50090-1635-0 5 mL in a BOTTLE, DROPPER Product: 50090-1635NDC: 50090-1635-0 5 mL in a BOTTLE, DROPPER
×
Clinical Information
Chemical Structure
No Image found
Clinical Pharmacology
Epinastine is a topically active, direct H-receptor antagonist and an inhibitor of the release of histamine from the mast cell. Epinastine is selective for the histamine H-receptor and has affinity for the histamine H receptor. Epinastine also possesses affinity for the α, α-, and 5-HT–receptors.
Non-Clinical Toxicology
None
Array
Patients should be instructed to avoid allowing the tip of the dispensing container to contact the eye, surrounding structures, fingers, or any other surface in order to avoid contamination of the solution by common bacteria known to cause ocular infections. Serious damage to the eye and subsequent loss of vision may result from using contaminated solutions.
Bottle should be kept tightly closed when not in use.
×
Reference
This information is obtained from the National Institute of Health's Standard Packaging Label drug database.
"https://dailymed.nlm.nih.gov/dailymed/"
While we update our database periodically, we cannot guarantee it is always updated to the latest version.
Clonazepam Description
Each single-scored tablet, for oral administration, contains 0.5 mg, 1 mg, or 2 mg Clonazepam, USP, a benzodiazepine. Each tablet also contains corn starch, lactose monohydrate, magnesium stearate, microcrystalline cellulose, and povidone. Clonazepam tablets USP 0.5 mg contain Yellow D&C No. 10 Aluminum Lake. Clonazepam tablets USP 1 mg contain Yellow D&C No. 10 Aluminum Lake, as well as FD&C Blue No. 1 Aluminum Lake.
Chemically, Clonazepam, USP is 5-(o-chlorophenyl)-1,3-dihydro-7-nitro-2H-1,4-benzodiazepin-2-one. It is a light yellow crystalline powder. It has the following structural formula:
C15H10ClN3O3 M.W. 315.72
×
Tips
Tips
×
Interactions
Interactions
A total of 440 drugs (1549 brand and generic names) are known to interact with Imbruvica (ibrutinib).
228 major drug interactions (854 brand and generic names)
210 moderate drug interactions (691 brand and generic names)
2 minor drug interactions (4 brand and generic names)
Show all medications in the database that may interact with Imbruvica (ibrutinib).
